/Companies

Benchsci

Toronto, US · Founded 2015 · 211 employees on LinkedIn · 15 known investors

Find your way into Benchsci

Sign up to see every warm intro you have to Benchsci

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Benchsci team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.

Founders & leadership

Benchsci was founded in 2015 by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, and Tom Leung.

DQDavid Qixiang Chen, PhD
David Qixiang Chen, PhDCo-Founder, Chief Innovation Officer (CINO), Director of AI2020–2020
EW
Elvis WiandaCo-founder · Chief Data Officer
LBLiran Belenzon
Liran BelenzonFounder and CEOHe previously served as a commander in the Israel Defense Forces and founded an e-commerce B2B marketplace in Israel; he earned an MBA from the University of Toronto's Rotman School of Management.
TLTom Leung
Tom LeungFounderTom Leung is Co-founder and Chief Science Officer of BenchSci, which develops AI-powered tools for preclinical drug discovery by extracting experimental evidence from scientific literature to help researchers select reagents and model systems.
DQ
David Q. ChenFounder

Investors · 15

500 Globallisted by 500 GlobalPalo Alto · $150K

How we know: open dataset · 500 Global portfolio 2026-08 · Not right? Tell us

Frequently asked questions

What does Benchsci do?
BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.
Who founded Benchsci?
Benchsci was founded by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung in 2015.
Who are Benchsci's investors?
Benchsci's investors include Inovia Capital, Generation Investment Management, Gradient Ventures, TCV, 500 Global, Afore Capital, BDC Growth Venture Fund, Creative Destruction Lab (CDL) and 7 more.
Where is Benchsci headquartered?
Benchsci is headquartered in Toronto, US.